Needham & Company LLC reissued their buy rating on shares of CompoSecure (NASDAQ:CMPO – Free Report) in a report published on Monday,Benzinga reports. The firm currently has a $16.00 target price on the stock.
Several other equities research analysts also recently issued reports on the stock. Benchmark lifted their price target on shares of CompoSecure from $12.00 to $17.00 and gave the stock a “buy” rating in a research note on Wednesday, September 18th. Lake Street Capital boosted their price target on CompoSecure from $14.00 to $18.00 and gave the stock a “buy” rating in a research note on Wednesday, October 2nd. JPMorgan Chase & Co. raised their price objective on CompoSecure from $8.00 to $12.00 and gave the company a “neutral” rating in a research note on Tuesday, August 20th. Compass Point upped their target price on CompoSecure from $11.50 to $14.50 and gave the company a “buy” rating in a research report on Tuesday, August 20th. Finally, Bank of America increased their target price on CompoSecure from $9.00 to $10.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $15.79.
Read Our Latest Report on CompoSecure
CompoSecure Stock Down 3.5 %
CompoSecure (NASDAQ:CMPO – Get Free Report) last released its quarterly earnings results on Friday, November 8th. The company reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.02). The company had revenue of $107.14 million during the quarter, compared to analysts’ expectations of $105.11 million. CompoSecure had a negative return on equity of 14.87% and a negative net margin of 5.63%. During the same quarter in the prior year, the company earned $0.24 EPS. Analysts anticipate that CompoSecure will post 1.02 EPS for the current fiscal year.
Insider Transactions at CompoSecure
In related news, Director Michele Logan sold 10,017,983 shares of the company’s stock in a transaction that occurred on Tuesday, September 17th. The stock was sold at an average price of $7.55, for a total transaction of $75,635,771.65. Following the sale, the director now directly owns 2,043,320 shares of the company’s stock, valued at approximately $15,427,066. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, insider Adam Joseph Lowe sold 5,730 shares of CompoSecure stock in a transaction dated Wednesday, September 11th. The shares were sold at an average price of $12.05, for a total value of $69,046.50. Following the completion of the transaction, the insider now directly owns 1,292,219 shares of the company’s stock, valued at approximately $15,571,238.95. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Michele Logan sold 10,017,983 shares of the stock in a transaction dated Tuesday, September 17th. The stock was sold at an average price of $7.55, for a total transaction of $75,635,771.65. Following the sale, the director now owns 2,043,320 shares in the company, valued at approximately $15,427,066. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,641,727 shares of company stock worth $80,370,824. 74.99% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On CompoSecure
Several institutional investors have recently made changes to their positions in CMPO. Pacific Ridge Capital Partners LLC boosted its position in CompoSecure by 146.9% during the 2nd quarter. Pacific Ridge Capital Partners LLC now owns 486,462 shares of the company’s stock valued at $3,308,000 after purchasing an additional 289,451 shares during the period. Boston Partners boosted its holdings in shares of CompoSecure by 40.8% during the first quarter. Boston Partners now owns 557,136 shares of the company’s stock valued at $4,028,000 after acquiring an additional 161,333 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of CompoSecure by 165.4% during the second quarter. Renaissance Technologies LLC now owns 209,389 shares of the company’s stock valued at $1,424,000 after acquiring an additional 130,489 shares during the period. Bailard Inc. acquired a new stake in shares of CompoSecure in the 2nd quarter worth about $259,000. Finally, Rhumbline Advisers lifted its position in CompoSecure by 17.3% in the 2nd quarter. Rhumbline Advisers now owns 19,521 shares of the company’s stock valued at $133,000 after purchasing an additional 2,877 shares during the last quarter. 37.56% of the stock is owned by institutional investors.
About CompoSecure
CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.
See Also
- Five stocks we like better than CompoSecure
- Why Are These Companies Considered Blue Chips?
- Rocket Lab is the Right Stock for the Right Time
- The Significance of Brokerage Rankings in Stock Selection
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- How to Use the MarketBeat Stock Screener
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for CompoSecure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompoSecure and related companies with MarketBeat.com's FREE daily email newsletter.